- Home
- POLA vs EVOK Comparison
POLA vs EVOK Comparison
Compare POLA & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- EVOK
- Stock Information
- Founded
- POLA 1979
- EVOK 2007
- Country
- POLA United States
- EVOK United States
- Employees
- POLA N/A
- EVOK N/A
- Industry
- POLA Industrial Machinery/Components
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- POLA Miscellaneous
- EVOK Health Care
- Exchange
- POLA Nasdaq
- EVOK Nasdaq
- Market Cap
- POLA 5.3M
- EVOK 5.4M
- IPO Year
- POLA 2016
- EVOK 2013
- Fundamental
- Price
- POLA $1.90
- EVOK $5.70
- Analyst Decision
- POLA
- EVOK
- Analyst Count
- POLA 0
- EVOK 0
- Target Price
- POLA N/A
- EVOK N/A
- AVG Volume (30 Days)
- POLA 26.0K
- EVOK 309.4K
- Earning Date
- POLA 08-13-2025
- EVOK 08-19-2025
- Dividend Yield
- POLA N/A
- EVOK N/A
- EPS Growth
- POLA N/A
- EVOK N/A
- EPS
- POLA N/A
- EVOK N/A
- Revenue
- POLA $13,918,000.00
- EVOK $11,594,083.00
- Revenue This Year
- POLA N/A
- EVOK $57.82
- Revenue Next Year
- POLA N/A
- EVOK $59.12
- P/E Ratio
- POLA N/A
- EVOK N/A
- Revenue Growth
- POLA 8.08
- EVOK 89.89
- 52 Week Low
- POLA $1.53
- EVOK $1.94
- 52 Week High
- POLA $4.69
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- POLA 44.05
- EVOK 65.19
- Support Level
- POLA $1.85
- EVOK $3.43
- Resistance Level
- POLA $1.97
- EVOK $4.70
- Average True Range (ATR)
- POLA 0.13
- EVOK 0.50
- MACD
- POLA -0.03
- EVOK 0.07
- Stochastic Oscillator
- POLA 12.20
- EVOK 95.38
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.